Notice of Proposed Sale · 144
Tango Therapeutics, Inc.
TNGXNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- TANGO THERAPEUTICS, INC.
- Issuer CIK
- 0001819133
- SEC file number
- 001-39485
- Phone
- 8573204900
- Person for whose account securities are to be sold
- ADAM CRYSTAL
- Relationships to issuer
- Officer
- Street
- 201 BROOKLINE AVENUE, SUITE 901
- City
- BOSTON
- State / country code
- MA
- Postal code
- 02215
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 81,000 | 2,201,580.00 | 144,647,982 | 08/03/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/03/2026 | Exercise of Stock Options | Issuer | 81,000 | N | 08/03/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for ADAM CRYSTAL | Common | 07/01/2026 | 27,000 | 798,907.20 |
| 10b5-1 Sales for ADAM CRYSTAL | Common | 06/01/2026 | 27,000 | 617,571.00 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for ADAM CRYSTAL
- Street
- 201 BROOKLINE AVENUE, SUITE 901
- City
- BOSTON
- State / country code
- MA
- Postal code
- 02215
Seller — prior-sale row 2, entry 1
- Name
- 10b5-1 Sales for ADAM CRYSTAL
- Street
- 201 BROOKLINE AVENUE, SUITE 901
- City
- BOSTON
- State / country code
- MA
- Postal code
- 02215
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Notice signature
- Notice date
- 08/03/2026
- Signed
- /s/ Adam Crystal
- Plan adoption dates
- 10/27/2025
Company context
Tango Therapeutics is a clinical-stage biotechnology company dedicated to delivering breakthrough targeted therapies that extend and improve the lives of patients with cancer. Using an approach that focuses on genetic vulnerabilities in cancer, Tango is pursuing PRMT5-targeted therapies designed to address pancreatic and other forms of cancer while sparing healthy normal tissues.